Literature DB >> 24816450

ADSC therapy in neurodegenerative disorders.

Tzu-Min Chan1, Julia Yi-Ru Chen, Li-Ing Ho, Hui-Ping Lin, Kuo-Wei Hsueh, Demeral David Liu, Yi-Hung Chen, An-Cheng Hsieh, Nu-Man Tsai, Dueng-Yuan Hueng, Sheng-Tzeng Tsai, Pei-Wen Chou, Shinn-Zong Lin, Horng-Jyh Harn.   

Abstract

Neurodegenerative disorders, chronic diseases that can severely affect the patient's daily life, include amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's diseases. However, these diseases all have the common characteristic that they are due to degenerative irreversibility, and thus no efficient drugs or therapy methods can mitigate symptoms completely. Stem cell therapy, such as adipose tissue-derived stem cells (ADSCs), is a promising treatment for incurable disorders. In this review, we summarized the previous studies using ADSCs to treat neurodegenerative disorders, as well as their therapeutic mechanisms. We also suggested possible expectations for future human clinical trials involving minimized intracerebroventricular combined with intravenous administration, using different cell lineages to finish complementary therapy as well as change the extracellular matrix to create a homing niche. Depending on successful experiments in relevant neurodegenerative disorders models, this could form the theoretical basis for future human clinical trials.

Entities:  

Mesh:

Year:  2014        PMID: 24816450     DOI: 10.3727/096368914X678445

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  17 in total

1.  Health Span-Extending Activity of Human Amniotic Membrane- and Adipose Tissue-Derived Stem Cells in F344 Rats.

Authors:  Dajeong Kim; Jangbeen Kyung; Dongsun Park; Ehn-Kyoung Choi; Kwang Sei Kim; Kyungha Shin; Hangyoung Lee; Il Seob Shin; Sung Keun Kang; Jeong Chan Ra; Yun-Bae Kim
Journal:  Stem Cells Transl Med       Date:  2015-08-27       Impact factor: 6.940

Review 2.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

Review 3.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

Review 4.  Stem cell therapies in age-related neurodegenerative diseases and stroke.

Authors:  Yuan Wang; Xunming Ji; Rehana K Leak; Fenghua Chen; Guodong Cao
Journal:  Ageing Res Rev       Date:  2016-11-19       Impact factor: 10.895

Review 5.  The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Biochem Soc Trans       Date:  2018-03-09       Impact factor: 5.407

6.  Adipose-derived stem cell-conditioned medium protects fibroblasts at different senescent degrees from UVB irradiation damages.

Authors:  Shu Guo; Ting Wang; Shuangyi Zhang; Peng Chen; Zheng Cao; Wenqin Lian; Jiayan Guo; Yue Kang
Journal:  Mol Cell Biochem       Date:  2019-10-10       Impact factor: 3.396

7.  Adult mesenchymal stem cells and women's health.

Authors:  Arnold I Caplan
Journal:  Menopause       Date:  2015-02       Impact factor: 2.953

8.  Concentrated Conditioned Media from Adipose Tissue Derived Mesenchymal Stem Cells Mitigates Visual Deficits and Retinal Inflammation Following Mild Traumatic Brain Injury.

Authors:  Kumar Abhiram Jha; Mickey Pentecost; Raji Lenin; Lada Klaic; Sally L Elshaer; Jordy Gentry; John M Russell; Alex Beland; Anton Reiner; Veronique Jotterand; Nicolas Sohl; Rajashekhar Gangaraju
Journal:  Int J Mol Sci       Date:  2018-07-11       Impact factor: 5.923

Review 9.  Neural transcription factors: from embryos to neural stem cells.

Authors:  Hyun-Kyung Lee; Hyun-Shik Lee; Sally A Moody
Journal:  Mol Cells       Date:  2014-09-18       Impact factor: 5.034

10.  Protective effects of alpha phenyl-tert-butyl nitrone and ascorbic acid in human adipose derived mesenchymal stem cells from differently aged donors.

Authors:  Adiv A Johnson; Yahaira Naaldijk; Christian Hohaus; Hans Jörg Meisel; Ilona Krystel; Alexandra Stolzing
Journal:  Aging (Albany NY)       Date:  2016-09-15       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.